New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a disease leading to the death of motor neurons (MNs). It is also recognized as a non‐cell autonomous disease where glial cells in the CNS are involved in its pathogenesis and progression. However, although denervation of neuromuscular junctions (NMJs) represents an early and major event in ALS, the importance of glial cells at this synapse receives little attention. An interesting possibility is that altered relationships between glial cells and MNs in the spinal cord in ALS may also take place at the NMJ. Perisynaptic Schwann cells (PSCs), which are glial cells at the NMJ, show great morphological and functional adaptability to ensure NMJ stability, maintenance and repair. More specifically, PSCs change their properties according to the state of innervation. Hence, abnormal changes or lack of changes can have detrimental effects on NMJs in ALS. This review will provide an overview of known and hypothesized interactions between MN nerve terminals and PSCs at NMJs during development, aging and ALS‐induced denervation. These neuron–PSC interactions may be crucial to the understanding of how degenerative changes begin and progress at NMJs in ALS, and represent a novel therapeutic target. image
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008 · cited 4×
“Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a rapid and progressive loss of upper and lower motor neurons (MNs) (Ilieva et al. 2009).”
BackgroundInfluentialTargeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670 · cited 1×
“However, even in this human cell-based model, controversial results have been reported (Sareen et al. 2013), emphasizing the crucial need to understand the intrinsic electrical properties of MNs and the ability of MNs to generate an appropriate synaptic output at the NMJ. Synaptic transmission at…”
BackgroundSaxena, S., Roselli, F., Singh, K., Leptien, K., Julien, J.-P., Gros-Louis, F., & Caroni, P. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.027 · Cited by 275 · cited 4×
“It has been suggested that MN excitability and activation might influence the progression rates of motor dysfunction, MN death and NMJ denervation (Gordon et al. 2010; Saxena et al. 2013).”
BackgroundInfluentialEndo, F., Komine, O., Fujimori-Tonou, N., Katsuno, M., Jin, S., Watanabe, S., Sobue, G., Dezawa, M., Wyss-Coray, T., & Yamanaka, K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.053 · Cited by 207
Dewil, M., dela Cruz, V. F., Van Den Bosch, L., & Robberecht, W. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.023 · Cited by 133 · cited 3×
“Indeed, several in vivo studies reveal a complete dissociation between MN death and NMJ denervation (Gould et al. 2006; Dewil et al. 2007; Suzuki et al. 2007), identifying the presynaptic nerve terminal of the MN and its environment as one potential site of distinctive mutation-mediated toxicity.”
BackgroundKawamata, H., Ng, S. K., Diaz, N., Burstein, S., Morel, L., Osgood, A., Sider, B., Higashimori, H., Haydon, P. G., Manfredi, G., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2689-13.2014 · Cited by 97 · cited 3×
“…resulting in profound effects on PSC Ca2+ signalling and synaptic transmission at the NMJ. Mutant SOD1 expression also increases Ca2+ accumulation in the motor nerve terminal (Siklos et al. 1996) and yields abnormal ER Ca2+ release in cultured SOD1G93A astrocytes (Kawamata et al. 2014).”
BackgroundTam, S. L., & Gordon, T. (2003) · Journal of Neurobiology · doi:10.1002/neu.10276 · Cited by 70 · cited 2×
“In fact, the number of bridges and sprouting is regulated by synaptic activity (Love et al. 2003; Tam & Gordon, 2003).”
Background
Cited by
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
Beers, D. R., & Appel, S. H. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30394-6 · Cited by 388
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Cappello, V., & Francolini, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102092 · Cited by 119
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD
Starr, A., & Sattler, R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.011 · Cited by 78
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
Dalla Bella, E., Bersano, E., Antonini, G., Borghero, G., Capasso, M., Caponnetto, C., Chiò, A., Corbo, M., Filosto, M., Giannini, F., et al. (2021) · Brain · doi:10.1093/brain/awab167 · Cited by 59
Lee, J. D., McDonald, T. S., Fung, J. N. T., & Woodruff, T. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02019-9 · Cited by 35
Metadata
- Authors
- Arbour, D., Vande Velde, C., & Robitaille, R.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2016-12
- Volume
- 595
- Issue
- 3
- Pages
- 647-661
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2559777674
- Cited by
- 75
- References
- 7
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. https://app.cochat.ai/papers/10.1113/jp270213
- The paper
- Arbour, D., Vande Velde, C., & Robitaille, R. (2017). New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. The Journal of Physiology. https://doi.org/10.1113/jp270213
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.